Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 412.50
-3.50 (-0.84%)
Sep 8, 2026, 1:30 PM CST
Bora Pharmaceuticals Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 19,557 | 19,014 | 17,427 | 14,200 | 10,494 | 4,900 |
Revenue Growth | 0.30% | 9.11% | 22.72% | 35.31% | 114.18% | 172.28% |
Gross Profit Gross Profit Growth | 7,817 | 7,853 | 7,791 | 6,991 | 2,913 | 1,672 |
Operating Income Operating Income Growth | 3,015 | 3,294 | 3,708 | 5,249 | 1,922 | 1,046 |
Net Income Net Income Growth | 1,547 | 2,981 | 3,853 | 3,030 | 1,392 | 749.74 |
Earnings Per Share EPS Growth | 7.84 | 15.81 | 27.29 | 24.50 | 11.78 | 6.42 |
EPS Growth | -72.35% | -42.08% | 11.42% | 107.94% | 83.40% | 28.53% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
CDMO Operations Department CDMO Operations Department Growth | 9,719 | 8,838 | 6,920 | 5,437 | 4,835 | 4,418 |
Other Operations Department Other Operations Department Growth | 1,211 | 845.31 | 802.33 | 273.38 | 202.85 | 85.09 |
Sales Operations Department Sales Operations Department Growth | 15,115 | 14,768 | 15,310 | 9,251 | 5,761 | 532.39 |
Adjustments and Eliminations Adjustments and Eliminations Growth | -6,487 | -5,437 | -5,606 | -761.19 | -304 | -135.84 |
Total Total Growth | 19,557 | 19,014 | 17,427 | 14,200 | 10,494 | 4,900 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,488 | 5,136 | 5,917 | 3,396 | 3,529 | 910.75 |
Total Debt Total Debt Growth | 21,815 | 18,227 | 18,973 | 4,991 | 7,596 | 2,219 |
Net Cash (Debt) Net Cash Growth | -13,328 | -13,091 | -13,056 | -1,595 | -4,067 | -1,308 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -71.04 | -69.41 | -92.49 | -12.84 | -34.34 | -11.20 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3,123 | 4,504 | 980.02 | 4,614 | 2,010 | 1,237 |
Capital Expenditures CapEx Growth | -1,110 | -928.67 | -528.1 | -297.71 | -194.81 | -163.48 |
Free Cash Flow Free Cash Flow Growth | 2,014 | 3,575 | 451.92 | 4,316 | 1,815 | 1,073 |
Free Cash Flow Growth | -47.53% | 691.04% | -89.53% | 137.76% | 69.15% | 3657.55% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.97% | 41.30% | 44.70% | 49.23% | 27.76% | 34.12% |
Operating Margin | 15.41% | 17.32% | 21.28% | 36.97% | 18.32% | 21.35% |
Pretax Margin | 14.01% | 27.76% | 29.97% | 28.62% | 17.53% | 20.90% |
Profit Margin | 7.91% | 15.68% | 22.11% | 21.34% | 13.26% | 15.30% |
FCF Margin | 10.30% | 18.80% | 2.59% | 30.39% | 17.30% | 21.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 10.000 | 10.000 | 11.669 | 10.002 | 5.133 | 2.041 |
Dividend Per Share Growth | -14.30% | -14.30% | 16.67% | 94.84% | 151.53% | 118.14% |
Dividend Yield | 2.43% | 2.10% | 1.95% | 1.99% | 2.07% | 2.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.77 | 20.30 | 20.17 | 21.32 | 22.36 | 16.60 |
Forward PE | 14.40 | 11.87 | 16.07 | 21.03 | 11.57 | 14.97 |
P/FCF Ratio | 26.30 | 16.93 | 171.96 | 14.97 | 17.14 | 11.60 |
PS Ratio | 2.71 | 3.18 | 4.46 | 4.55 | 2.97 | 2.54 |